CTA101 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT04026100 · UNKNOWN
Trial details
- NCT number
- NCT04026100
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2022-08-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.